Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection

Vaccine

Volumn 14, Issue 10, 1996, Pages 959-962

  Oliveira, Sergio C ^a   Splitter, Gary A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Brucella abortus; Recombinant vaccine; Ribosomal protein

Indexed keywords

HYBRID PROTEIN; IMMUNOLOGICAL ADJUVANT; MALTOSE BINDING PROTEIN; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; RIBOSOME PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BRUCELLA ABORTUS; BRUCELLOSIS; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOBLOTTING; INFECTION PREVENTION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030198334     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00018-7     Document Type: Article

References (27)

1. 1 Nicoletti, P.L. Relationship between animal and human disease. In: Brucellosis: Clinical and Laboratory Aspects (Eds Young, E.J. and Corbel, M.J.). CRC Press, Inc., Boca Raton, FL, 1989, pp. 41-51
2. 2 Young, E.J. Brucellosis: a model zoonosis in developing countries. APMIS Suppl. 1988, 3, 17-20
3. 3 Enright, F.M. The pathogenesis and pathobiology of Brucella infection in domestic animals. In: Animal Brucellosis (Eds Nielsen, K. and Duncan, J.R.). CRC Press, Inc., Boca Raton, FL, 1990, pp. 301-320
4. 4 Young, E.J. Human brucellosis Rev. Infect. Dis. 1983, 5, 821-842
5. 5 Nicoletti, P.L. The control of brucellosis - a veterinary responsibility. Saudi Med. J. 1992, 13, 10-13
6. 6 Corner, L.A. and Alton, G.G. Persistence of Brucella abortus strain 19 infection in adult cattle vaccinated with reduced doses. Res. Vet. Sci. 1981, 31, 342-344
7. 7 Cheville, N.F., Stevens, M.G., Jensen, A.E., Tatum, F.M. and Halling, S.M. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Am. J. Vet. Res. 1993, 54, 1591-1597
8. 8 Araya, L.N., Elzer, P.H., Rowe, G.E., Enright, F.M. and Winter, A.J. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J. Immunol. 1989, 143, 3330-3337
9. 9 Mielke, M.E. T cell subsets in granulomatous inflammation and immunity to L. monocytogenes and B. abortus. Behring Inst. Mitt. 1991, 88, 99-111
10. 10 Baldwin, C.L., Jiang, X. and Fernandes, D.M. Macrophage control of Brucella abortus: influence of cytokines and iron. Trends Microbiol. 1993, 1, 99-104
11. 11 Brooks-Worrell, B.M. and Splitter, G.A. Antigens of Brucella abortus S19 immunodominant for bovine lymphocytes as identified by one-and two-dimensional cellular immunoblotting. Infect. Immun. 1992, 60, 2459-2464
12. + T cells. Immunology 1994, 83, 659-664
13. 13 Oliveira, S.C. and Splitter, G.A. Subcloning and expression of the Brucella abortus L7/L12 ribosomal gene and T-lymphocyte recognition of the recombinant protein. Infect. Immun. 1994, 62, 5201-5204
14. 14 Bachrach, G., Banai, M., Bardenstein, S., Hoida, G., Genizi, A. and Bercovier, H. Brucella ribosomal protein L7/L12 is a major component in the antigenicity of Brucellin INRA for Delayed-Type Hypersensitivity in Brucella-sensitized guinea pigs. Infect. Immun. 1994, 62, 5361-5366
15. 15 Skeiky, Y.A.W., Guderian, J.A., Benson, D.R. et al. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. J. Exp. Med. 1995, 181, 1527-1537
16. 16 Gregory, R.L. Microbial ribosomal vaccine. Rev. Infect. Dis. 1986, 8, 208-217
17. 17 Dutta, S.K., Shankarappa, B. and Mattingly-Napier, B.L. Molecular cloning and analysis of recombinant major antigens of Ehrlichia risticii. Infect. Immun. 1991, 59, 1162-1169
18. 18 Ling, I.T., Ogun, S.A. and Holder, A.A. Immunization against malaria with a recombinant protein. Parasite Immunol. 1994, 16, 63-67
19. 19 Malik, A., Gross, M., Ulrich, T. and Hoffman, S.L. Induction of cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein by immunization with soluble recombinant protein without adjuvant. Infect. Immun. 1993, 61, 5062-5066
20. 20 Montaraz, J.A. and Winter, A.J. Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect. Immun. 1986, 53, 245-251
21. 21 Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685
22. 22 Confer, A.W., Tabatabai, L.B., Deyoe, B.L. et al. Vaccination of cattle with chemically modified and unmodified salt-extractable proteins from Brucella abortus. Vet. Microbiol. 1987, 15, 325-339
23. 23 Ray, W.C. An assessment of investigations conducted in the USA on Brucella abortus strain 45/20 bacterins. Dev. Biol. Stand. 1975, 31, 335-342
24. 24 Winter, A.J. and Rowe, G.E. Comparative immune responses to native cell envelope antigens and hot sodium dodecyl sulfate insoluble fraction (PG) of Brucella abortus in cattle and mice. Vet. Immunol. Immunopathol. 1988, 18, 149-163
25. 25 Pugh Jr, G. and Tabatabai, L.B. Alteration of protective and serologic responses in BALB/c mice vaccinated with chemically modified versus nonmodified proteins of Brucella abortus 19. Infect. Immun. 1994, 62, 5327-5334
26. 26 Gelber, R.H., Mehra, V., Bloom, B., Murray, L.P., Siu, P., Tsang, M. and Brenan, P.J. Vaccination with pure Mycobacterium leprae proteins inhibits M. leprae multiplication in mouse footpads. Infect. Immun. 1994, 62, 4250-4255
27. 27 Khusmith, S., Charoenvit, Y., Kumar, S., Sedegah, M., Beaudoin, R.L. and Hoffman, S.L. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 1991, 252, 715-718